The Creek laboratory at Monash Institute of Pharmaceutical Sciences uses advanced metabolomics and systems pharmacology to investigate drug action in pathogens
The latest paper from our lab identified extracellular metabolites of Pseudomonas aeruginosa correlated with ceftolozane/tazobactam-resistant subpopulations and modelled the time-courses of these metabolites @JessTait_PKPD @CreekLab@CRE_RESPOND
https://t.co/N5Kq29YHpi
@CreekLab & MIPS team introduces Orbitrap Astral MS for faster throughput, higher sensitivity, & deeper proteome coverage. Supported by a $3m grant from the Medical Research Future Fund, the platform fosters collabs among institutions & industry partners.
https://t.co/ns66Eoye55
Just published - ex vivo evaluation of 12 repurposed drugs for COVID https://t.co/nUIBpevkOS
Nature Portfolio's highlight https://t.co/JLAWu1uOdX of our paper on repurposing method https://t.co/1YRQTY4bmD
Thank you to great team, including @ssvasan@CreekLab@CarlkRx
Honoured to be awarded @arc_gov_au future fellowship #FT22 to study malaria parasite metabolism!!! This is only possible thanks to my amazing team and many collaborators. @MIPS_Australia#GlobalHealthTPA
Get ready for our Mid-Year Symposium!! Focusing on all things #multiomics and held at @Bio21Institute with some fantastic speakers. Its free AND hybrid, so you really don't have an excuse not to come. Register now at https://t.co/l0GJDJsEqt! #proteomics#metabolomics#lipidomics